Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Glycemic actions of alanine and terbutaline in IDDM
B. V. Wiethop
, P. E. Cryer
Institute of Clinical and Translational Sciences (ICTS)
Division of Endocrinology, Metabolism & Lipid Research
Research output
:
Contribution to journal
›
Article
›
peer-review
31
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Glycemic actions of alanine and terbutaline in IDDM'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Neuroscience
Alanine
100%
Terbutaline
100%
Blood Plasma
50%
Glucagon
25%
C Peptide
16%
Placebo
8%
Hypoglycemia
8%
Catecholamine
8%
Fatty Acids
8%
Amino Acid
8%
Noradrenalin Release
8%
Research Design
8%
Sympathomimetic Drug
8%
Keyphrases
Terbutaline
100%
Plasma Glucose
41%
Non-diabetic
33%
Insulin
25%
Glucagon
25%
C-peptide
16%
Placebo
8%
Amino Acids
8%
Iatrogenic Hypoglycemia
8%
Fatty Acid Composition
8%
Norepinephrine Release
8%
Insulin Level
8%
Adrenergic Agonist
8%
Glycemic Response
8%
Non-esterified Fatty Acids
8%
Catecholamine Levels
8%
Euglycemic
8%
Initial Effect
8%